Gain Therapeutics, Inc. (GANX): Total Assets
$22.82M
As of 2025-12-31
$15.42M
As of 2026-06-30
-1.8%
3-year compound annual growth
+18.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.82M | +88.2% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $12.12M | -34.9% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $18.61M | -22.8% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $24.10M | -38.2% | 2024-03-26, Balance as of period end |
| 2021-12-31 | $38.99M | +305.9% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $9.60M | n/a | 2022-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $22.82M | +88.2% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $22.90M | -49.5% |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | $22.13M | +30.7% |
| BriaCell Therapeutics Corp. (BCTX) | 2025-07-31 | $21.65M | +268.7% |
| Immunic, Inc. (IMUX) | 2025-12-31 | $24.05M | -41.1% |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $24.16M | -61.2% |
| Phio Pharmaceuticals Corp. (PHIO) | 2025-12-31 | $21.49M | +274.5% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $24.25M | -33.5% |
Compare GANX, CRVO, FTH, MBRX side by side · Screen every company in Pharmaceutical Preparations ↗